West Pharmaceutical Services, Inc. Peer Comparison

Metric Value Ranking
Market Cap $21.7 Billion 3/12 BDX
$69.3B		 RMD
$35.1B		 WST
$21.7B		 COO
$21.5B		 HOLX
$18.5B		 BAX
$18.4B		 TFX
$11.5B		 RGEN
$8.0B		 MMSI
$5.6B		 ICUI
$4.4B		 HAE
$4.1B		 EMBC
$804.4M
Gross Margin 33% 12/12 EMBC
69%		 COO
61%		 RMD
58%		 HOLX
56%		 TFX
56%		 HAE
50%		 MMSI
47%		 BDX
46%		 RGEN
45%		 BAX
36%		 ICUI
35%		 WST
33%
Profit Margin 16% 3/12 RMD
24%		 HOLX
19%		 WST
16%		 HAE
11%		 TFX
11%		 MMSI
11%		 BDX
10%		 COO
10%		 EMBC
5%		 RGEN
2%		 ICUI
-4%		 BAX
-8%
EBITDA margin 24% 7/12 EMBC
34%		 HOLX
33%		 RMD
31%		 COO
28%		 BDX
26%		 TFX
26%		 WST
24%		 HAE
22%		 MMSI
21%		 BAX
17%		 ICUI
13%		 RGEN
13%
Quarterly Revenue $702.0 Million 7/12 BDX
$5.0B		 BAX
$3.8B		 RMD
$1.2B		 HOLX
$1.0B		 COO
$1.0B		 TFX
$749.7M		 WST
$702.0M		 ICUI
$595.8M		 MMSI
$337.6M		 HAE
$336.2M		 EMBC
$272.5M		 RGEN
$154.1M
Quarterly Earnings $111.3 Million 4/12 BDX
$487.0M 		RMD
$292.2M 		HOLX
$194.5M 		WST
$111.3M 		COO
$104.7M 		TFX
$80.0M 		HAE
$38.4M 		MMSI
$35.7M 		EMBC
$14.7M 		RGEN
$3.3M 		ICUI
-$21.4M 		BAX
-$314.0M
Quarterly Free Cash Flow $64.8 Million 5/12 BDX
$1.1B 		RMD
$415.2M 		HOLX
$361.9M 		COO
$118.5M 		WST
$64.8M 		ICUI
$60.1M 		MMSI
$57.2M 		TFX
$56.5M 		RGEN
$34.8M 		BAX
-$1.0M 		EMBC
-$11.8M 		HAE
-$33.1M
Trailing 4 Quarters Revenue $2.9 Billion 6/12 BDX
$19.8B		 BAX
$15.0B		 RMD
$4.5B		 HOLX
$3.3B		 TFX
$3.0B		 WST
$2.9B		 COO
$2.9B		 ICUI
$2.3B		 HAE
$1.3B		 MMSI
$1.3B		 EMBC
$1.1B		 RGEN
$602.4M
Trailing 4 Quarters Earnings $524.9 Million 5/12 BDX
$5.0B 		BAX
$3.8B 		RMD
$1.2B 		HOLX
$1.0B 		COO
$1.0B 		TFX
$749.7M 		WST
$702.0M 		ICUI
$595.8M 		MMSI
$337.6M 		HAE
$336.2M 		EMBC
$272.5M 		RGEN
$154.1M
Quarterly Earnings Growth -28% 8/12 HOLX
580% 		MMSI
76% 		RMD
27% 		COO
23% 		BDX
20% 		EMBC
-3% 		HAE
-7% 		WST
-28% 		TFX
-28% 		RGEN
-83% 		ICUI
-115% 		BAX
-123%
Annual Earnings Growth -9% 7/12 BAX
27611% 		COO
76% 		MMSI
43% 		EMBC
22% 		HOLX
14% 		RMD
10% 		WST
-9% 		HAE
-11% 		BDX
-18% 		TFX
-23% 		ICUI
-80% 		RGEN
-102%
Quarterly Revenue Growth -7% 12/12 RMD
9% 		COO
8% 		HAE
8% 		ICUI
8% 		MMSI
5% 		HOLX
3% 		BAX
3% 		BDX
2% 		TFX
1% 		RGEN
-3% 		EMBC
-5% 		WST
-7%
Annual Revenue Growth -1% 9/12 HAE
9% 		MMSI
7% 		TFX
5% 		BDX
3% 		BAX
2% 		RMD
2% 		ICUI
2% 		EMBC
0% 		WST
-1% 		RGEN
-15% 		COO
-19% 		HOLX
-20%
Cash On Hand $446.2 Million 6/12 BDX
$4.5B 		HOLX
$2.4B 		BAX
$2.1B 		RGEN
$809.1M 		MMSI
$638.7M 		WST
$446.2M 		HAE
$344.4M 		ICUI
$302.6M 		EMBC
$281.8M 		TFX
$238.6M 		RMD
$238.4M 		COO
$109.9M
Short Term Debt $154.1 Million 3/12 BAX
$2.5B 		BDX
$1.2B 		WST
$154.1M 		TFX
$93.8M 		RGEN
$81.6M 		ICUI
$69.9M 		COO
$40.8M 		HOLX
$40.7M 		RMD
$35.2M 		EMBC
$17.8M 		MMSI
$11.7M 		HAE
$5.1M
Long Term Debt $72.9 Million 12/12 BDX
$18.1B		 BAX
$10.4B		 COO
$2.6B		 HOLX
$2.5B		 TFX
$1.6B		 EMBC
$1.6B		 ICUI
$1.6B		 HAE
$1.2B		 RMD
$838.8M		 MMSI
$801.3M		 RGEN
$517.7M		 WST
$72.9M
PE 41.43 5/12 COO
59.75		 MMSI
47.89		 BDX
47.50		 TFX
43.61		 WST
41.43		 HAE
35.33		 RMD
34.38		 HOLX
26.41		 EMBC
11.54		 BAX
7.41		 ICUI
-1.00		 RGEN
-1.00
PS 7.56 3/12 RGEN
13.32		 RMD
7.72		 WST
7.56		 COO
7.47		 HOLX
5.70		 MMSI
4.32		 TFX
3.82		 BDX
3.50		 HAE
3.04		 ICUI
1.91		 BAX
1.22		 EMBC
0.72
PB 8.44 1/12 WST
8.44		 RMD
7.22		 HAE
4.48		 MMSI
4.39		 RGEN
4.04		 HOLX
3.74		 COO
2.71		 BDX
2.68		 TFX
2.52		 BAX
2.38		 ICUI
2.16		 EMBC
0.00
PC 48.74 3/12 COO
195.35		 RMD
147.24		 WST
48.74		 TFX
48.18		 BDX
15.44		 ICUI
14.56		 HAE
11.78		 RGEN
9.91		 MMSI
8.81		 BAX
8.76		 HOLX
7.60		 EMBC
2.85
Liabilities to Equity 0.35 11/12 BAX
2.43		 HAE
1.81		 BDX
1.15		 ICUI
1.10		 MMSI
0.85		 HOLX
0.80		 TFX
0.63		 COO
0.53		 RGEN
0.44		 RMD
0.41		 WST
0.35		 EMBC
0.00
ROA 0.15 1/12 WST
15% 		RMD
15% 		BAX
9% 		HOLX
8% 		HAE
5% 		MMSI
5% 		EMBC
5% 		TFX
4% 		BDX
3% 		COO
3% 		RGEN
0% 		ICUI
-2%
ROE 0.20 3/12 BAX
32% 		RMD
21% 		WST
20% 		HOLX
14% 		HAE
13% 		MMSI
9% 		BDX
6% 		TFX
6% 		COO
5% 		RGEN
0% 		ICUI
-3% 		EMBC
-9%
Current Ratio 3.82 1/12 WST
3.82		 RMD
3.42		 RGEN
3.27		 COO
2.89		 TFX
2.58		 HOLX
2.26		 MMSI
2.18		 ICUI
1.91		 BDX
1.87		 HAE
1.55		 BAX
1.41		 EMBC
0.62
Quick Ratio 0.49 4/12 COO
59.75		 MMSI
47.89		 BDX
47.50		 TFX
43.61		 WST
41.43		 HAE
35.33		 RMD
34.38		 HOLX
26.41		 EMBC
11.54		 BAX
7.41		 ICUI
-1.00		 RGEN
-1.00
Long Term Debt to Equity 0.03 11/12 BAX}
1.37		 HAE}
1.35		 ICUI}
0.76		 BDX}
0.70		 MMSI}
0.62		 HOLX}
0.51		 TFX}
0.36		 COO}
0.33		 RGEN}
0.26		 RMD}
0.17		 WST}
0.03		 EMBC}
-2.08
Debt to Equity 0.12 11/12 BAX
1.75		 HAE
1.35		 ICUI
0.82		 BDX
0.75		 MMSI
0.68		 HOLX
0.52		 TFX
0.40		 RGEN
0.37		 COO
0.33		 RMD
0.18		 WST
0.12		 EMBC
-2.16
Burn Rate -6.39 10/12 HAE
29.58		 TFX
28.51		 RGEN
21.41		 COO
12.14		 BDX
8.37		 EMBC
5.28		 ICUI
2.99		 BAX
1.55		 RMD
-0.95		 WST
-6.39		 HOLX
-29.00		 MMSI
-866.16
Cash to Cap 0.02 9/12 EMBC
0.35		 HOLX
0.13		 BAX
0.11		 MMSI
0.11		 RGEN
0.10		 HAE
0.08		 ICUI
0.07		 BDX
0.06		 WST
0.02		 TFX
0.02		 RMD
0.01		 COO
0.01
CCR 0.58 8/12 RGEN
10.48		 BDX
2.23		 HOLX
1.86		 MMSI
1.60		 RMD
1.42		 COO
1.13		 TFX
0.71		 WST
0.58		 BAX
0.00		 EMBC
-0.80		 HAE
-0.86		 ICUI
-2.81
EV to EBITDA 127.38 2/12 RGEN}
393.53		 WST}
127.38		 RMD}
93.73		 COO}
85.23		 MMSI}
80.78		 ICUI}
74.03		 TFX}
67.31		 HAE}
67.17		 BDX}
65.58		 HOLX}
55.47		 BAX}
46.69		 EMBC}
23.44
EV to Revenue 7.51 4/12 RGEN
13.21		 COO
8.35		 RMD
7.86		 WST
7.51		 HOLX
5.73		 MMSI
4.50		 TFX
4.35		 BDX
4.24		 HAE
3.70		 ICUI
2.51		 BAX
1.97		 EMBC
1.94

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions